Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€327.35
Target price
02.08.24
€355.55
Performance (%)
39.39%
Price
26.07.24
€456.30
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc. has seen massive gains of 39.39%. This prediction currently runs until 02.08.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 0.974% | 0.974% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by BMO_Capital_Markets for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $385.00 to $389.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
10.38%
26.07.24
26.07.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.80
07.11.23
07.11.23
€388.11
07.11.24
07.11.24
27.53%
26.07.24
26.07.24